 |
 |

Preoperative Autologous Blood Donations Before Elective Hysterectomy
Michael H. Kanter, MD;
Darlene van Maanen, MT(ASCP);
Karl H. Anders, MD;
Fernando Castro, MT(ASCP);
Win Win Mya, MD;
Kathy Clark
JAMA. 1996;276(10):798-801.
Abstract
 |  |
Objective. —To determine whether preoperative autologous blood donation is justified for patients undergoing elective abdominal or vaginal hysterectomy.
Design. —Retrospective cohort study.
Patients and Setting. —A total of 263 consecutive patients admitted for elective abdominal or vaginal hysterectomy to a community health maintenance organization hospital during 1993 and 1994.
Main Outcome Measures. —Evaluation of transfusion rates for patients who did and did not donate autologous blood; determination of any risk factors that would predict the need for transfusion; and evaluation of the need for transfusion based on chart review.
Results. —Of 263 patients, 26 received a blood transfusion. The major risk factor identified for transfusion was the donation of autologous blood. Of 140 patients who donated autologous blood, 25 were transfused, whereas just 1 patient of 123 who did not donate autologous blood was transfused (P<.001). Patients who donated autologous blood had significantly lower mean admission hemoglobin level than patients who did not donate (119 g/L vs 132 g/L; P<.05); logistic regression showed that autologous donation was an independent risk factor for transfusion.
>Conclusion. —For hysterectomy patients, donation of autologous blood causes anemia and is associated with a more liberal transfusion policy. These 2 factors result in a markedly increased incidence of transfusion with its associated risks. Elimination of preoperative autologous donation for these patients should not result in frequent exposure to allogeneic blood.
Author Affiliations
From Kaiser Permanente Medical Center, Woodland Hills, Calif (Drs Kanter and Anders, and Mss van Maanen and Clark); Kaiser Permanente Medical Center, Panorama City, Calif (Mr Castro and Dr Mya); and the Department of Pathology and Laboratory Medicine, University of California at Los Angeles (Drs Kanter and Anders).
Footnotes
Reprints: Michael H. Kanter, MD, Department of Pathology, Kaiser Permanente, 5601 De Soto Ave, Woodland Hills, CA 91365.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
A Blood-Conservation Algorithm to Reduce Blood Transfusions After Total Hip and Knee Arthroplasty
Pierson et al.
JBJS 2004;86:1512-1518.
ABSTRACT
| FULL TEXT
Preoperative Use of Recombinant Human Erythropoietin Before Total Joint Arthroplasty
Bezwada et al.
JBJS 2003;85:1795-1800.
ABSTRACT
| FULL TEXT
Perioperative Blood Management Practices in Elective Orthopaedic Surgery
Keating and Meding
J Am Acad Orthop Surg 2002;10:393-400.
ABSTRACT
| FULL TEXT
The Reduction of Preoperative Autologous Blood Donation for Primary Total Hip or Knee Arthroplasty: The Effect on Subsequent Transfusion Rates
Couvret et al.
Anesth. Analg. 2002;94:815-823.
ABSTRACT
| FULL TEXT
Aprotinin Decreases Exposure to Allogeneic Blood During Primary Unilateral Total Hip Replacement
Murkin et al.
JBJS 2000;82:675-675.
ABSTRACT
| FULL TEXT
Preoperative Autologous Donation for Total Joint Arthroplasty. An Analysis of Risk Factors for Allogenic Transfusion
HATZIDAKIS et al.
JBJS 2000;82:89-100.
ABSTRACT
| FULL TEXT
Transfusion Medicine -- Blood Conservation- Second of Two Parts
Goodnough et al.
NEJM 1999;340:525-533.
FULL TEXT
Preoperative Autologous Donation Decreases Allogeneic Transfusion but Increases Exposure to All Red Blood Cell Transfusion: Results of a Meta-analysis
Forgie et al.
Arch Intern Med 1998;158:610-616.
ABSTRACT
| FULL TEXT
AUTOLOGOUS BLOOD DONATIONS INADVISABLE BEFORE HYSTERECTOMY
JWatch General 1996;1996:2-2.
FULL TEXT
|